Advisor Group, Inc. - KERYX BIOPHARMACEUTICALS INC ownership

KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 132 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.76 and the average weighting 0.0%.

Quarter-by-quarter ownership
Advisor Group, Inc. ownership history of KERYX BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2018$65,000
+30.0%
19,290
+45.1%
0.00%0.0%
Q2 2018$50,000
-23.1%
13,290
-16.4%
0.00%0.0%
Q1 2018$65,000
-18.8%
15,890
-8.9%
0.00%0.0%
Q4 2017$80,000
+33.3%
17,440
+109.0%
0.00%0.0%
Q3 2017$60,000
-13.0%
8,345
-12.8%
0.00%0.0%
Q2 2017$69,000
-76.6%
9,565
-80.0%
0.00%
-83.3%
Q1 2017$295,000
-4.2%
47,885
-8.6%
0.01%
-14.3%
Q4 2016$308,000
+51.7%
52,390
+37.7%
0.01%
+40.0%
Q3 2016$203,000
-6.0%
38,055
+15.9%
0.01%
-16.7%
Q2 2016$216,00032,8300.01%
Other shareholders
KERYX BIOPHARMACEUTICALS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Old West Investment Management, LLC 1,068,719$3,633,0001.50%
Abrams Capital Management 9,108,867$30,970,0000.82%
Baupost Group 25,791,678$87,692,0000.67%
Bristol Advisors, LLC 51,100$174,0000.29%
RICE HALL JAMES & ASSOCIATES, LLC 2,228,059$7,575,0000.27%
NEXTHERA CAPITAL LP 200,000$680,0000.13%
LINCOLN CAPITAL CORP 37,280$127,0000.10%
Meridian Wealth Management, LLC 49,600$169,0000.07%
Rubric Capital Management LP 199,883$680,0000.07%
Virtus ETF Advisers LLC 155,009$527,0000.05%
View complete list of KERYX BIOPHARMACEUTICALS INC shareholders